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Abstract Pepsin is an aspartic protease that acts in food di-
gestion in the mammal stomach. An optimal pH of around
2 allows pepsin to operate in its natural acidic environment,
while at neutral pH the protein is denatured. Although the pH
dependence of pepsin activity has been widely investigated since
the 40s, a renewed interest in this protein has been fuelled by its
homology to the HIV and other aspartic proteases. Recently, an
inactive pepsin conformation has been identi¢ed that accumu-
lates at mildly acidic pH, whose structure and properties are
largely unknown. In this paper, we analyse the conformation of
pepsin at di¡erent pHs by a combination of spectroscopic tech-
niques, and obtain a detailed characterisation of the intermedi-
ate. Our analysis indicates that it is the dominant conformation
from pH 4 to 6.5. Interestingly, its near UV circular dichroism
spectrum is identical to that of the native conformation that
appears at lower pH values. In addition, we show that the in-
termediate binds the active site inhibitor pepstatin with a
strength similar to that of the native conformation. Pepsin
thus adopts, in the 6.5^4.0 pH interval, a native-like although
catalytically inactive conformation. The possible role of this
intermediate during pepsin transportation to the stomach lumen
is discussed.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Pepsin is a well-known enzyme whose activity has been
extensively studied since Northrop crystallised it in 1929 [1].
It belongs, together with catepsin D, quinosine, renine and the
HIV-protease amongst others, to the family of the aspartic
proteases, that display a high degree of structural homology
[2]. The recognition of the HIV-protease as a member of this
family [3] has renewed the interest in this type of enzymes and
in their inhibition [4]. There is a wide range of speci¢c inhib-
itors that can bind to the active site and e¡ectively remove the
activity of pepsin. One of the best known ones is pepstatin [5],
that, at acidic pH, tightly binds to the catalytic site of both
pepsin and its precursor: pepsinogen [6,7]. The pepstatin^pep-
sinogen complex, however, cannot be formed above pH 3
because the active site is blocked by a propeptide sequence
[6,8,9]. Below pH 5, pepsinogen is self-cleaved to produce
active pepsin [10].
Pepsin is a monomeric, two domain, mainly L-protein, with
a high percentage of acidic residues (43 out of 327) leading to
a very low pI. The catalytic site is formed by two aspartate
residues, Asp32 and Asp215, one of which has to be proton-
ated, and the other deprotonated, for the protein to be active
[11]. This occurs in the 1^5 pH interval [12,13]. Above pH 7,
pepsin is in a denatured conformation that retains some sec-
ondary structure [14,15]. This denaturation is not fully revers-
ible [16], the lack of reversibility being attributed to the
N-terminal domain [17]. In the 5^7 pH interval the conforma-
tion of pepsin is poorly characterised. Although some confor-
mational changes experienced by pepsin in the acidic region
have been reported [16,18], the intermediate conformations
associated to them have not been studied in detail. We present
here a detailed spectroscopic characterisation of the structure
of pepsin and of its competence towards pepstatin binding in
the 1^10 pH interval. We identify an intermediate pepsin con-
formation dominant at mildly acidic pH that, although cata-
lytically non-competent, is essentially native and binds pepsta-
tin. Based on this, we hypothesise that this intermediate could
play a role during pepsin transportation to the stomach lu-
men.
2. Materials and methods
2.1. Protein and peptides
Crystallised, highest grade pepsin was purchased from Sigma and
used without further puri¢cation. Its concentration was calculated
using an extinction coe⁄cient of 51 mM31 cm31 and was of 5 WM
in £uorescence experiments, 10 WM in near- and in far-UV circular
dichroism (CD), and 30 WM in molecular exclusion experiments. Pep-
statin was purchased from USB Corp. (Cleveland, OH). A 30 WM
concentration was used for the CD and £uorescence experiments.
The control peptide Ac-GGGGGG-NH2 was ordered to Sigma
Genosys and used to examine whether the e¡ects exerted by pepstatin
on the pH-related pepsin transitions where speci¢c.
2.2. pH measurements
A 1 mM sodium borate, 1 mM sodium citrate, 1 mM sodium
phosphate and 25 mM sodium chloride bu¡er was used, adjusted to
di¡erent pH values as required. This bu¡er allows to work at a con-
stant ionic strength in a wide pH interval. The pH was measured with
a Crison micro pH-meter calibrated before each experiment. The pH
of every solution was measured immediately before and after each
spectroscopic measurement, and the two values were always the
same within experimental error (30.03 pH units).
2.3. Fluorescence and CD measurements
Fluorescence measurements were performed at 25.0H 0.1‡C in a
thermostated Aminco-Bowman Series 2 spectrofotometer from Spec-
tronic Instruments, using a 1 cm cuvette. The cuvette was sealed for
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measurement in order to minimise changes in pH. Fluorescence pH
titration curves were acquired at an emission wavelength of 355 nm
(with excitation at 280 nm). CD measurements have been made in a
JASCO 710 spectropolarimeter thermostatised at 25H 0.1‡C. For the
far- and near-UV CD measurements a 10 WM pepsin solution was
used in a 1 mm or 1 cm cuvette, respectively. Far- and near-UV
titration curves were recorded at 215 and 290 nm, respectively, as
the greatest changes occurred at those wavelengths.
2.4. Molecular exclusion chromatography measurements
Molecular exclusion experiments were performed in an FPLC sys-
tem with a Superose 12 HR 10/30 column from Pharmacia, calibrated
with proteins of known molecular weight. In all experiments a 30 WM
pepsin solution was injected in a preequilibriated column and then
eluted with the same bu¡er.
2.5. Data ¢tting
Depending on the spectroscopic technique used, one or two pH-
related transitions are observed whose slopes are related to the num-
ber of protons involved in the process. The £uorescence and far-UV
CD curves showed two transitions that were ¢tted to a three-state
model (Scheme 1) using Eq. 1:
F ¼ FD þ F I 10
3a þ FN103ðaþbÞ
1þ 103a þ 103ðaþbÞ ð1Þ
where D is the denatured conformation above pH 7 that takes up n
protons to became the I, intermediate conformation, that takes up m
protons to became the N, native conformation at low pH; FD, FI and
FN are the spectroscopic signals of the denatured, intermediate and
native state, respectively; a=m(pH3pK1) ; and b= n(pH3pK2).
The near-UV CD and molecular exclusion curves can be ¢tted to a
two-state transition (Scheme 2) using Eq. 2:
F ¼ FD þ F I 10
3b
1þ 103b ð2Þ
where everything has the same meaning as in Scheme 1 and Eq. 1.
3. Results and discussion
3.1. pH-linked £uorescence transitions in pepsin
The £uorescence intensity of pepsin at 355 nm has been
monitored from pH 9 to 2, at 25.0H 0.1‡C in a bu¡er of
constant ionic strength. Two evident transitions are observed
(Fig. 1a). As the pH approaches neutrality from the alcaline
region, there is a sudden increase in £uorescence intensity with
an apparent pKa of 6.8 (Table 1), and then a plateau is
reached that extends from pH 6.5 to 4.5. At lower pH values
a second transition occurs, with a pKa of 3.5, that lowers the
intensity. The two transitions are perfectly mimicked by
changes in the wavelength of maximal £uorescence emission
(Fig. 1b) from where pKas of 6.8 and 3.7 can be calculated.
These double transitions reveal the accumulation of an inter-
mediate pepsin conformation that is dominant in the 6.5 to
4.0 interval. In general, little structural insight can be obtained
from protein £uorescence intensity curves because the £uores-
cence intensity of a polypeptide, as it becomes more tightly
packed, can both increase or decrease. In addition, £uores-
cence intensity changes depend on the wavelength used to
monitor the transitions. In contrast, the wavelength of max-
imal emission is usually more informative as it is related to the
degree of solvent exposure of tryptophan residues. The data in
Fig. 1b indicate that the pepsin tryptophan residues are, in the
intermediate, more buried than in the unfolded state but less
than in the active conformation at very low pH. The wave-
length changes are however quite small (specially that from
the intermediate to the active form) and could even be due to
titration of acidic residues close to £uorescent ones. It should
be pointed out that the denatured conformation at pH 9.0 is
not fully unfolded according to its wavelength of maximal
Scheme 1.
Scheme 2.
Fig. 1. a: Fluorescence intensity at 355 nm of pepsin (open circles)
and of a pepsin^pepstatin complex (solid circles) as a function of
pH, ¢tted to a three-state equation. b: Wavelength of maximal £uo-
rescence emission of pepsin (open circles), of a pepsin^pepstatin
complex (closed circles) and of a mixture of pepsin with a control
peptide not expected to bind pepsin (open triangles) as a function
of pH, ¢tted to a three-state equation. The spectra were measured
from 300 to 400, with excitation at 280 nm. Pepsin, pepstatin and
control peptide concentrations were 5, 30 and 30 WM, respectively,
and the bu¡er: 1 mM sodium borate, 1 mM sodium citrate, 1 mM
sodium phosphate and 25 mM sodium chloride.
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emission, far from the typical 355 nm of polypeptides with
fully exposed tryptophan residues. One further transition oc-
curs above pH 9.0 (not shown) that brings the emission max-
imum close to 355 nm. One interesting detail is that, although
the transition from the native to the intermediate state is fully
reversible, the higher pH transition, from intermediate to de-
natured, is only partially reversible (data not shown). This
means that the analysis of the second transition yields only
an approximation of the pKas. In addition, we have noticed
that short incubation times up to 2 h are not enough to
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Fig. 2. CD spectra of pepsin and of a pepsin^pepstatin complex at
several pH values. a: Far-UV CD spectra from 250 to 200 nm:
pepsin at pH 9.46 (solid triangles), pH 5.52 (open triangles) and pH
1.81 (half-¢lled triangles); pepsin^pepstatin complex at pH 9.00 (sol-
id circles), pH 5.51 (open circles) and pH 1.78 (half-¢lled circles).
b: Near-UV CD spectra of pepsin from 310 to 260 nm: pH 8.70 (solid
circles), pH 7.39 (open circles), pH 6.65 (solid triangles), pH 5.62
(open triangles), pH 4.26 (solid stars) and pH 2.21 (open stars). The
pepsin and pepstatin concentrations used were 10 and 30 WM, re-
spectively, and the bu¡er: 1 mM sodium borate, 1 mM sodium cit-
rate, 1 mM sodium phosphate and 25 mM sodium chloride.
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equilibrate the samples. For this reason we have used longer
equilibration times (5^12 h) to gather the curves shown in
Figs. 1 and 3. After 5 h of equilibration the curves are inde-
pendent of the equilibration time, which suggests they are true
equilibrium curves and therefore the reported pKa values for
the higher pH transition are essentially correct.
3.2. pH-linked far- and near-UV CD transitions in pepsin
Using a combination of techniques to monitor transitions
associated to changes in solution conditions (pH, temperature,
denaturant concentration, etc.) can help detect conformations
that may pass undetected by using a single technique and
often provides useful insight into the structure of the inter-
mediates [19,20]. To further investigate the conformation of
pepsin at di¡erent pH values, we have recorded far- and near-
UV CD spectra and pH titration curves from pH 9 to 2. The
far-UV CD spectra are shown in Fig. 2a. As already suggested
by the £uorescence data, the high pH spectrum is consistent
with some residual secondary structure being present in the
denatured conformation. In addition, a titration curve has
been recorded following the ellipticity at 215 nm, a wave-
length that can, in principle, report on the content of beta
structure. The curve, shown in Fig. 3a, is similar to the £uo-
rescence curves in that it shows two transitions. The calcu-
lated pKa for the higher pH transition (6.8) agrees very well
with those found by £uorescence intensity and £uorescence
wavelength. As for the lower pH transition, the agreement
is only qualitative as it is a bit higher (4.4) than those found
by £uorescence. The higher pH transition is associated with
an increase (in absolute value) of the ellipticity at 215 nm and
a decrease of the 205 minimum (Fig. 2a), which is consistent
with an increase in secondary structure content. The lower pH
transition, where the ellipticity decreases (in absolute value)
may be interpreted as a debilitation of non-native secondary
structure elements present in the intermediate conformation
but it could also re£ect a change in the contribution of aro-
matic residues to the far UV CD spectrum [21].
More revealing is the evolution of the near-UV CD spec-
trum as a function of pH. The spectra in Fig. 2b indicates
that, as the pH is lowered from the alcaline region, a well-
de¢ned near-UV CD spectrum develops re£ecting that some
aromatic residues of pepsin become ¢xed in a stable asymmet-
ric environment characteristic of well-folded conformations.
Interestingly, there is no noticeable change from pH 6 to 2,
which suggests that the delicate environment of the aromatic
residues that give rise to the spectrum is the same in the
intermediate and in the low pH active conformation. This is
con¢rmed by the titration curve (Fig. 3b) that can be ¢tted to
a single two-state transition with a pKa of 7.3, not identical
but close to that found for the ¢rst transition by the other
techniques used. It is not clear why the near UV CD spec-
Fig. 3. Far-UV CD at 215 nm (a) and near-UV CD at 290 nm. (b)
of pepsin (open circles) and of a pepsin^pepstatin complex (solid
circles) as a function of pH, ¢tted to a three-state and to a two-
state equation, respectively. The pepsin and pepstatin concentrations
were 10 WM and 30 WM, respectively, and the bu¡er: 1 mM sodium
borate, 1 mM sodium citrate, 1 mM sodium phosphate and 25 mM
sodium chloride.
Fig. 4. Apparent size of pepsin as a function of pH, ¢tted to a two-
state equation. Pepsin concentration was 30 WM in bu¡er 1 mM so-
dium borate, 1 mM sodium citrate, 1 mM sodium phosphate and
25 mM sodium chloride.
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trum, usually very sensitive to conformational changes, does
not signi¢cantly vary from pH 6 to 2, especially when both
the far-UV CD and the £uorescence spectra clearly change in
this region. One possible explanation is that the change in
conformation in going from intermediate to native is con¢ned
to one of the two pepsin domains while the speci¢c aromatic
residues responsible for the near-UV CD spectrum (at 290 nm
some of the tryptophan residues) are con¢ned to the other.
Since both the N- and C-terminal domains contain trypto-
phan residues (two and three respectively) it is not possible
to assess which domain is being a¡ected by the low pH con-
formational transition.
3.3. Pepsin apparent size as a function of pH
The apparent size of pepsin as a function of pH is shown in
Fig. 4. At low pH the protein exhibits unrealistically high
elution volumes (too low apparent molecular masses), indica-
tive of an interaction with the column matrix (not shown).
This precludes the characterisation of the lower pH transition
in terms of apparent size. Above pH 6, the interaction with
the column is less strong and pepsin is eluted at volumes
consistent with its molecular mass. From pH 6.5 to higher
values, the elution volume decreases as the pH increases, re-
£ecting the expansion associated to the denaturation transi-
tion. The elution volume data can be ¢tted (Fig. 4) to a
sigmoidal curve with an apparent pKa of 6.8 (Table 1).
3.4. Conformational states of pepsin in di¡erent pH regions
The pKa data obtained using £uorescence intensity, £uores-
cence wavelength of maximal emission, near-UV CD, far-UV
CD and size exclusion chromatography (Table 1) o¡er a very
clear picture. Above pH 7, pepsin is in an expanded confor-
mation, devoid of well-de¢ned tertiary interactions, with a
reduced secondary structure content but still compact enough
to manifest signi¢cant tryptophan burial and to contain some
secondary structure. This conformation is enzymatically inac-
tive and has been reported to experience a further unfolding
event with an apparent pKa of 11.5 [15]. At around pH 6.8
pepsin folds to an intermediate conformation, as shown by the
¢ve di¡erent techniques used to monitor the transition. The
slight di¡erence between the pKa calculated by near-UV CD
and by the other techniques suggests the transition may not be
two-state. Compared to the denatured state, the intermediate
displays a higher content of secondary structure, and a higher
degree of tryptophan burial. Most revealingly, its near-UV
CD spectrum is consistent with that of a well-folded confor-
mation and, indeed, it is identical to that of the native active
conformation at low pH. The size of the intermediate is also
consistent with its postulated well-folded structure. All this
together is a strong indication that the intermediate adopts
a conformation very similar to the native one and that its lack
of enzyme activity is only due to an inappropriate ionisation
state of one of the active site residues. At lower pH values
(around pH 3.5), the intermediate evolves to the native, active
conformation. As in the case of the higher pH transition, a
small but signi¢cant discrepancy between the pKas calculated
from the far-UV CD curves and from the other techniques
suggests the intermediate to native transition may involve ad-
ditional species in the transition region. Our analysis, together
with the data in ref. [15] allows us to propose the following
scheme that summarises the conformational states adopted by
pepsin in di¡erent pH regions:
In Scheme 3, A denotes the active conformation, I the in-
termediate conformation (inactive but native-like), D1 the de-
natured conformation that appears at neutral pH (and that
still contains some secondary structure), and D2 the more
unfolded conformation at high pH.
3.5. Pepsin/pepstatin binding to the intermediate and native
conformations
The native-like characteristics found for the intermediate
conformation dominant from pH 6.5 to 4.5 prompted us to
question whether it would contain a well-formed substrate
binding site. To address this issue we have pH-titrated pep-
statin/pepsin mixtures and followed their spectroscopic prop-
erties in parallel to those of pepsin. According to the dissoci-
ation constant of the complex at pH 2, 1.3U1038 [22], the
concentrations of enzyme and inhibitor used ensure that more
than 99% of the pepsin molecules are bound to pepstatin at
this pH value.
The binding of pepstatin to the native and to the intermedi-
ate pepsin conformations, but not to the denatured state, is
re£ected by an increase in the ellipticity at 215 nm (Fig. 2a) in
the presence of the inhibitor. In contrast, the spectrum of the
denatured conformation, at pH 9, does not change at this
wavelength upon addition of pepstatin (the di¡erence between
the two spectra that can be observed at 205 nm is just the
signal of pepstatin).
The best way, however, to assess whether pepstatin binds to
the intermediate is to compare the spectroscopic pH pro¢les
of pepsin and of the pepsin/pepstatin mixtures. The £uores-
cence intensity, £uorescence wavelength of maximal emission,
near-UV CD and far-UV CD pro¢les shown in Figs. 1 and 3
display the same pattern: the signal of the denatured confor-
mation is never altered by the presence of pepstatin, which
strongly suggests pepstatin does not bind to the denatured
conformation. In contrast, all the spectroscopic signals of
the intermediate and native conformations are modi¢ed in
the presence of the inhibitor (except the emission wavelength
of the intermediate).
The binding of pepstatin to the intermediate is also indi-
cated by the signi¢cant pKa-shifts induced in the higher pH
transition, as can be observed in the far-UV CD and in the
£uorescence intensity and Vmax pH pro¢les (Figs. 1 and 3 and
Table 1). Pepstatin increases these pKa values by around 0.5
pH units and sets them quite close to the pKa of the near-UV
CD curve (Table 1), which suggests that in the presence of
pepstatin the high pH transition becomes two-state. The ob-
served shifts in pKa values are certainly expected if pepstatin
binds to the intermediate but not to the denatured state be-
cause the presence of pepstatin in the solution will shift the
D^I equilibrium and favour the intermediate conformation
over the denatured one in a wider pH interval. As for the
low pH transition, the binding of pepstatin to the intermediate
and native states only produces small pKa changes, which
suggests that the strength of the native and of the intermediate
pepstatin complexes is similar.
Finally, we have checked that the pepstatin-induced spec-
troscopic and pKa changes are not unspeci¢c by studying a
Scheme 3.
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control peptide not expected to bind at the pepstatin binding
site. As shown in Fig. 1b, the control peptide fails to produce
the accurately determined change in pKa of the denatured/
intermediate transition (pK2) that is induced by pepstatin
and, indeed, the pH-titration curve of pepsin mixed with the
control peptide can be superimposed to that of free pepsin.
The pKa of the denatured/intermediate transition derived
from the £uorescence intensity curve is also the same as that
of free pepsin (Table 1).
3.6. Participation of the intermediate in pepsin transportation
to the stomach lumen
The stomach of mammals uses a complex system to gener-
ate an acidic environment in the gastric lumen and to main-
tain a pH gradient from the epithelial surface to the lumen
[23,24]. It is clear that pepsin at acidic pH can damage the
stomach cells. To avoid this harmful contact, there are cells in
the epithelial surface that, on the one hand, synthesise and
liberate a protective mucus shield whose glycoproteins capture
the protons produced by parietal cells, and, on the other,
release HCO33 that increases the pH [25,26]. As a conse-
quence, although the gastric lumen has a pH of around 2,
the combined e¡ect of proton release, neutralisation by the
glycoproteins, secretion of HCO33 in the epithelium and back
di¡usion of protons from the lumen, establishes a 7^2 pH
gradient across the mucus. When the mucus proteins reach
the lumen, pepsin degrades them and protons are released
[26]. Pepsin thus performs a double function: degradation of
ingested proteins and degradation of the mucus, with a con-
comitant release of protons.
Pepsin is produced from pepsinogen by intramolecular or
intermolecular cleavage. Between pH 5 and 4 the intermolec-
ular cleavage dominates, while at lower pHs the activation
tends to be intramolecular [27]. In its path to the lumen
(Fig. 5), pepsinogen is secreted to gastric crypts at low pH
(around 3) [28] where it can become enzymatically active and
generate pepsin, that continues its trip to the lumen. As soon
as pepsin reaches an area of pH above 4, it will adopt the
enzymatically inactive but well-folded intermediate conforma-
tion studied in this work. Since this intermediate retains a
native-like peptide binding site, we propose that it will get
bound to the proteins of the mucus, not degrading them,
and will thus be actively carried towards the lumen in this
bound state. Moreover, since above pH 4 the intramolecular
mechanism of activation is slow and since the intermolecular
mechanism is not operative because the pepsin molecules are
sequestered by their interaction with the mucus proteins, the
activation of pepsin will be e¡ectively halted near the crypts
openings. Then, as bound pepsin is transported towards the
lumen, encompassed with the movement of the mucus, it will
reach again areas of lower pH where it will become readily
active upon protonation because it is already in a native-like
conformation. In addition if some molecules enter in a higher
pH area near the epithelial cells, the protein will remain folded
and bound to the mucus and will recover its activity as soon
as it reenters a region of lower pH.
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